Industry Voices and Cannabis News | Page 104 of 135 | Cannabiz

Haleon terminates Cann Group agreement following failed S3 trial

by Steve Jones June 15, 2023April 30, 2024

GlaxoSmithKline’s consumer healthcare division, Haleon, has terminated its agreement with Cann Group after the failure of […]

Cann Group in multimillion-dollar cap raise to fund Mildura production growth

by Steve Jones June 15, 2023April 30, 2024

ANTG joins over-the-counter race with IBS clinical trial

by Steve Jones June 14, 2023April 30, 2024

ANTG subsidiary fined for alleged security ‘failures’ at cultivation site

by Steve Jones June 13, 2023April 30, 2024

BBS Pharmaceuticals to be wound up as focus turns to recovering A$3.5m from possible ‘voidable transactions’

by Steve Jones June 7, 2023April 30, 2024

Trademark row brews as Cannatrek looks to monopolise ‘T’ branding

by Steve Jones June 7, 2023April 30, 2024

Medlab still in limbo as talks continue with ‘interested parties’

by Steve Jones June 7, 2023April 30, 2024

Scrutiny of SAS-B data for psychiatric conditions exposes prescribing ‘disconnect’

by Steve Jones June 7, 2023April 30, 2024

Montu caught in second product dispute over ‘out of stock’ claims

by Steve Jones June 7, 2023April 30, 2024

Creso Pharma eyes Australian market as firm seeks GMP licence

by Steve Jones June 6, 2023April 30, 2024